Antithrombotic drugs and subarachnoid haemorrhage risk
Authors:
- Anton PottegårdAPAnton Pottegård
- Luis Alberto García RodríguezLRLuis Alberto García Rodríguez
- Frantz Rom PoulsenFPFrantz Rom Poulsen
- Jesper HallasJHJesper Hallas
- David GaistDGDavid Gaist
- 1 January 2015
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 114 (11) , 1064-1075
Abstract
Thrombosis and Haemostasis publishes original basic research and clinical studies in vascular biology and medicine, serving as an international platform for dissemination and debate of scientific information at the cutting edge.Keywords
This publication has 18 references indexed in Scilit:
- Antithrombotic drugs and risk of hemorrhagic stroke in the general populationNeurology, 2013
- Mortality after hemorrhagic strokeNeurology, 2013
- Lifetime risks for aneurysmal subarachnoid haemorrhage: multivariable risk stratificationJournal of Neurology, Neurosurgery & Psychiatry, 2013
- Aspirin as a Promising Agent for Decreasing Incidence of Cerebral Aneurysm RuptureStroke, 2011
- The Danish National Patient RegisterScandinavian Journal of Public Health, 2011
- Platelet aggregation inhibitors, vitamin K antagonists and risk of subarachnoid hemorrhageJournal of Thrombosis and Haemostasis, 2011
- Use of vitamin K antagonists and risk of subarachnoid haemorrhage: A population-based case-control studyEuropean Journal of Internal Medicine, 2010
- Antiplatelet drugs and risk of subarachnoid hemorrhage: a population‐based case‐control studyJournal of Thrombosis and Haemostasis, 2010
- Risk of subarachnoid haemorrhage in first degree relatives of patients with subarachnoid haemorrhage: follow up study based on national registries in DenmarkBMJ, 2000
- Intracranial AneurysmsNew England Journal of Medicine, 1997